With low- and middle-income countries (LMICs) increasingly and disproportionately affected by noncommunicable diseases (NCDs), equitable access to essential medicines and products is critical. However, medicine availability remains a challenge in many countries. In a WHO survey of 40 countries, NCD medicine availability in the public sector was only 36%. In response to this need, the Coalition developed an NCD Forecasting Tool for Essential Medicines and Products and accompanying toolkit, in partnership with the ministries of health in Kenya and Uganda.
Impact / Outcome
For the first time, Kenya budgeted for the cost of NCD commodities over the next five years in their national NCD strategy, with costing of hypertension and diabetes medicines being supported by the forecasting tool.
Funding sources
Public/Private
Key Metrics
Increase percentage of availability of the affordable basic technologies and essential medicines, including generics, required to treat major noncommunicable diseases in both public and private facilities
Operating model
Public-private partnershipYear published
01 January 2021